ELEVANCE HEALTH, INC. Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss)
ELEVANCE HEALTH, INC. (ELV) reported Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) of $29.00 million for the 12-month period ending 2025-12-31, per its 10-K filed 2026-02-06.
Financial Statements › Income Statement › Other Income
us-gaap:FairValueMeasurementWithUnobservableInputsReconciliationRecurringBasisAssetGainLossIncludedInOtherComprehensiveIncomeLoss · last filed 2026-02-06
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2023-12-31 was $2.00M.
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2023-09-30 was $1.00M, a 94.44% decline year-over-year.
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2023-06-30 was -$8.00M.
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for the quarter ending 2022-12-31 was -$33.00M.
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for fiscal 2025 was $29.00M, a 141.67% increase from fiscal 2024.
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for fiscal 2024 was $12.00M, a 33.33% increase from fiscal 2023.
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for fiscal 2023 was $9.00M.
- ELEVANCE HEALTH, INC. fair value, measurement with unobservable inputs reconciliation, recurring basis, asset, gain (loss) included in other comprehensive income (loss) for fiscal 2022 was -$17.00M, a 666.67% decline from fiscal 2021.
| Period end | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 3 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 3 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 6 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 6 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 9 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 9 month as first filed | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 12 month | Fair Value, Measurement with Unobservable Inputs Reconciliation, Recurring Basis, Asset, Gain (Loss) Included in Other Comprehensive Income (Loss) 12 month as first filed |
|---|---|---|---|---|---|---|---|---|
| 2025-12-31 | $29.00M 10-K · filed 2026-02-06 | |||||||
| 2024-12-31 | $12.00M 10-K · filed 2026-02-06 | |||||||
| 2023-12-31 | $2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-06 | $3.00M derived: sum of 2 quarters · filed 2026-02-06 | -$5.00M derived: sum of 3 quarters · filed 2026-02-06 | $9.00M 10-K · filed 2026-02-06 | ||||
| 2023-09-30 | $1.00M 10-Q · filed 2023-10-18 | -$7.00M derived: sum of 2 quarters · filed 2023-10-18 | $7.00M 10-Q · filed 2023-10-18 | |||||
| 2023-06-30 | -$8.00M 10-Q/A · filed 2023-09-29 | -$2.00M 10-Q/A · filed 2023-09-29 | ||||||
| 2022-12-31 | -$33.00M derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-20 | -$15.00M derived: sum of 2 quarters · filed 2025-02-20 | -$15.00M derived: sum of 3 quarters · filed 2025-02-20 | -$17.00M 10-K · filed 2025-02-20 | ||||
| 2022-09-30 | $18.00M 10-Q · filed 2023-10-18 | $18.00M derived: sum of 2 quarters · filed 2023-10-18 | $16.00M 10-Q · filed 2023-10-18 | $15.00M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-06-30 | $0.00 derived: 10-Q/A 6 month − 10-Q 3 month · filed 2023-09-29 | -$2.00M 10-Q/A · filed 2023-09-29 | -$3.00M derived: sum of 3 quarters · filed 2024-02-21 | -$4.00M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2022-03-31 | -$2.00M 10-Q · filed 2023-04-19 | -$3.00M derived: sum of 2 quarters · filed 2024-02-21 | -$4.00M derived: sum of 3 quarters · filed 2024-02-21 | -$1.00M derived: sum of 4 quarters · filed 2024-02-21 | ||||
| 2021-12-31 | -$1.00M derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-21 | -$2.00M derived: sum of 2 quarters · filed 2024-02-21 | $1.00M derived: sum of 3 quarters · filed 2024-02-21 | $3.00M 10-K · filed 2024-02-21 | ||||
| 2021-09-30 | -$1.00M 10-Q · filed 2022-10-19 | $2.00M derived: sum of 2 quarters · filed 2022-10-19 | $4.00M 10-Q · filed 2022-10-19 | $3.00M derived: sum of 4 quarters · filed 2023-10-18 | ||||
| 2021-06-30 | $3.00M 10-Q · filed 2022-07-20 | $6.00M 10-Q · filed 2022-07-20 | $4.00M derived: sum of 3 quarters · filed 2023-10-18 | $18.00M derived: sum of 4 quarters · filed 2023-10-18 | ||||
| 2021-03-31 | $3.00M 10-Q · filed 2022-04-20 | $1.00M derived: sum of 2 quarters · filed 2023-10-18 | $15.00M derived: sum of 3 quarters · filed 2023-10-18 | $8.00M derived: sum of 4 quarters · filed 2023-10-18 | ||||
| 2020-12-31 | -$2.00M derived: 10-Q 12 month − 10-Q 9 month · filed 2023-10-18 | $12.00M derived: sum of 2 quarters · filed 2023-10-18 | $5.00M derived: sum of 3 quarters · filed 2023-10-18 | -$5.00M 10-Q · filed 2023-10-18 | ||||
| 2020-09-30 | $14.00M 10-Q · filed 2021-10-20 | $7.00M derived: sum of 2 quarters · filed 2021-10-20 | -$3.00M 10-Q · filed 2021-10-20 | -$14.00M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-06-30 | -$7.00M 10-Q · filed 2021-07-21 | -$17.00M 10-Q · filed 2021-07-21 | -$28.00M derived: sum of 3 quarters · filed 2022-02-16 | -$16.00M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2020-03-31 | -$10.00M 10-Q · filed 2021-04-21 | -$21.00M derived: sum of 2 quarters · filed 2022-02-16 | -$9.00M derived: sum of 3 quarters · filed 2022-02-16 | -$9.00M derived: sum of 4 quarters · filed 2022-02-16 | ||||
| 2019-12-31 | -$11.00M derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-16 | $1.00M derived: sum of 2 quarters · filed 2022-02-16 | $1.00M derived: sum of 3 quarters · filed 2022-02-16 | $3.00M 10-K · filed 2022-02-16 | ||||
| 2019-09-30 | $12.00M 10-Q · filed 2020-10-28 | $12.00M derived: sum of 2 quarters · filed 2020-10-28 | $14.00M 10-Q · filed 2020-10-28 | $12.00M derived: sum of 4 quarters · filed 2021-02-18 | ||||
| 2019-06-30 | $0.00 10-Q · filed 2020-07-29 | $2.00M 10-Q · filed 2020-07-29 | $0.00 derived: sum of 3 quarters · filed 2021-02-18 | -$1.00M derived: sum of 4 quarters · filed 2021-02-18 | ||||
| 2019-03-31 | $2.00M 10-Q · filed 2020-04-29 | $0.00 derived: sum of 2 quarters · filed 2021-02-18 | -$1.00M derived: sum of 3 quarters · filed 2021-02-18 | -$4.00M derived: sum of 4 quarters · filed 2021-02-18 | ||||
| 2018-12-31 | -$2.00M derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-18 | -$3.00M derived: sum of 2 quarters · filed 2021-02-18 | -$6.00M derived: sum of 3 quarters · filed 2021-02-18 | -$5.00M 10-K · filed 2021-02-18 | ||||
| 2018-09-30 | -$1.00M 10-Q · filed 2019-10-23 | -$4.00M derived: sum of 2 quarters · filed 2019-10-23 | -$3.00M 10-Q · filed 2019-10-23 | $1.40M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2018-06-30 | -$3.00M 10-Q · filed 2019-07-24 | -$2.80M 10-Q · filed 2018-07-25 | -$2.00M 10-Q · filed 2019-07-24 | -$2.40M 10-Q · filed 2018-07-25 | $2.40M derived: sum of 3 quarters · filed 2020-02-19 | $7.40M derived: sum of 4 quarters · filed 2020-02-19 | ||
| 2018-03-31 | $400.00K 10-Q · filed 2018-04-25 | $5.40M derived: sum of 2 quarters · filed 2020-02-19 | $10.40M derived: sum of 3 quarters · filed 2020-02-19 | $11.00M derived: sum of 4 quarters · filed 2020-02-19 | ||||
| 2017-12-31 | $5.00M derived: 10-K 12 month − 10-Q 9 month · filed 2020-02-19 | $10.00M derived: sum of 2 quarters · filed 2020-02-19 | $10.60M derived: sum of 3 quarters · filed 2020-02-19 | $14.00M 10-K · filed 2020-02-19 | $14.20M 10-K · filed 2018-02-21 | |||
| 2017-09-30 | $5.00M 10-Q · filed 2018-10-31 | $4.80M 10-Q · filed 2017-10-25 | $5.60M derived: sum of 2 quarters · filed 2018-10-31 | $9.00M 10-Q · filed 2018-10-31 | $8.70M 10-Q · filed 2017-10-25 | $7.50M derived: sum of 4 quarters · filed 2019-02-20 | ||
| 2017-06-30 | $600.00K 10-Q · filed 2018-07-25 | $3.90M 10-Q · filed 2018-07-25 | $2.50M derived: sum of 3 quarters · filed 2019-02-20 | $1.90M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2017-03-31 | $3.30M 10-Q · filed 2018-04-25 | $1.90M derived: sum of 2 quarters · filed 2019-02-20 | $1.30M derived: sum of 3 quarters · filed 2019-02-20 | $2.80M derived: sum of 4 quarters · filed 2019-02-20 | ||||
| 2016-12-31 | -$1.40M derived: 10-K 12 month − 10-Q 9 month · filed 2019-02-20 | -$2.00M derived: sum of 2 quarters · filed 2019-02-20 | -$500.00K derived: sum of 3 quarters · filed 2019-02-20 | -$4.00M 10-K · filed 2019-02-20 | -$3.00M 10-K · filed 2017-02-22 | |||
| 2016-09-30 | -$600.00K 10-Q · filed 2017-10-25 | $900.00K derived: sum of 2 quarters · filed 2017-10-25 | -$2.60M 10-Q · filed 2017-10-25 | -$5.60M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-06-30 | $1.50M 10-Q · filed 2017-07-26 | -$2.00M 10-Q · filed 2017-07-26 | -$5.00M derived: sum of 3 quarters · filed 2018-02-21 | -$1.30M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2016-03-31 | -$3.50M 10-Q · filed 2017-04-26 | -$6.50M derived: sum of 2 quarters · filed 2018-02-21 | -$2.80M derived: sum of 3 quarters · filed 2018-02-21 | -$1.80M derived: sum of 4 quarters · filed 2018-02-21 | ||||
| 2015-12-31 | -$3.00M derived: 10-K 12 month − 10-Q 9 month · filed 2018-02-21 | $700.00K derived: sum of 2 quarters · filed 2018-02-21 | $1.70M derived: sum of 3 quarters · filed 2018-02-21 | $4.40M 10-K · filed 2018-02-21 | ||||
| 2015-09-30 | $3.70M 10-Q · filed 2016-11-02 | $4.70M derived: sum of 2 quarters · filed 2016-11-02 | $7.40M 10-Q · filed 2016-11-02 | $5.10M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-06-30 | $1.00M 10-Q · filed 2016-07-27 | $3.70M 10-Q · filed 2016-07-27 | $1.40M derived: sum of 3 quarters · filed 2017-02-22 | $1.10M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2015-03-31 | $2.70M 10-Q · filed 2016-04-27 | $400.00K derived: sum of 2 quarters · filed 2017-02-22 | $100.00K derived: sum of 3 quarters · filed 2017-02-22 | $16.90M derived: sum of 4 quarters · filed 2017-02-22 | ||||
| 2014-12-31 | -$2.30M derived: 10-K 12 month − 10-Q 9 month · filed 2017-02-22 | -$2.60M derived: sum of 2 quarters · filed 2017-02-22 | $14.20M derived: sum of 3 quarters · filed 2017-02-22 | $11.70M 10-K · filed 2017-02-22 | ||||
| 2014-09-30 | -$300.00K 10-Q · filed 2015-10-28 | $16.50M derived: sum of 2 quarters · filed 2015-10-28 | $14.00M 10-Q · filed 2015-10-28 | $13.60M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-06-30 | $16.80M 10-Q · filed 2015-07-29 | $14.30M 10-Q · filed 2015-07-29 | $13.90M derived: sum of 3 quarters · filed 2016-02-19 | $16.50M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2014-03-31 | -$2.50M 10-Q · filed 2015-04-29 | -$2.90M derived: sum of 2 quarters · filed 2016-02-19 | -$300.00K derived: sum of 3 quarters · filed 2016-02-19 | $5.40M derived: sum of 4 quarters · filed 2016-02-19 | ||||
| 2013-12-31 | -$400.00K derived: 10-K 12 month − 10-Q 9 month · filed 2016-02-19 | $2.20M derived: sum of 2 quarters · filed 2016-02-19 | $7.90M derived: sum of 3 quarters · filed 2016-02-19 | $6.60M 10-K · filed 2016-02-19 | ||||
| 2013-09-30 | $2.60M 10-Q · filed 2014-10-29 | $8.30M derived: sum of 2 quarters · filed 2014-10-29 | $7.00M 10-Q · filed 2014-10-29 | $1.70M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-06-30 | $5.70M 10-Q · filed 2014-07-30 | $4.40M 10-Q · filed 2013-07-24 | -$900.00K derived: sum of 3 quarters · filed 2015-02-24 | -$3.70M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2013-03-31 | -$1.30M 10-Q · filed 2014-04-30 | -$6.60M derived: sum of 2 quarters · filed 2015-02-24 | -$9.40M derived: sum of 3 quarters · filed 2015-02-24 | -$14.20M derived: sum of 4 quarters · filed 2015-02-24 | ||||
| 2012-12-31 | -$5.30M derived: 10-K 12 month − 10-Q 9 month · filed 2015-02-24 | -$8.10M derived: sum of 2 quarters · filed 2015-02-24 | -$12.90M derived: sum of 3 quarters · filed 2015-02-24 | -$33.10M 10-K · filed 2015-02-24 | ||||
| 2012-09-30 | -$2.80M 10-Q · filed 2013-10-23 | -$7.60M derived: sum of 2 quarters · filed 2013-10-23 | -$27.80M 10-Q · filed 2013-10-23 | |||||
| 2012-06-30 | -$4.80M 10-Q · filed 2013-07-24 | -$25.00M 10-Q · filed 2013-07-24 | ||||||
| 2012-03-31 | -$20.20M 10-Q · filed 2013-04-24 | |||||||
| 2011-12-31 | $1.30M 10-K · filed 2014-02-20 | |||||||
| 2010-12-31 | $35.60M 10-K · filed 2013-02-22 |
Similar stocks
| Stock Name | Country | Market Cap | PE Ratio |
|---|---|---|---|
| Cigna Group (CI) | United States | $70.160B | 10.44 |
| HUMANA INC (HUM) | United States | $45.651B | 18.44 |
| CENTENE CORP (CNC) | United States | $30.588B | -6.22 |
| MOLINA HEALTHCARE, INC. (MOH) | United States | $10.091B | -1,697.50 |
| Alignment Healthcare, Inc. (ALHC) | United States | $1.593B | 121.28 |
| TRUPANION, INC. (TRUP) | United States | $0.984B | |
| UNITEDHEALTH GROUP INC (UNH) | United States | $336.652B | 26.62 |